Froidevaux S - Search Results

1

Radiolabeled alpha-melanocyte-stimulating hormone analogs for receptor-mediated targeting of melanoma: from tritium to indium.

Eberle AN, Froidevaux S. Eberle AN, et al. Among authors: froidevaux s. J Mol Recognit. 2003 Sep-Oct;16(5):248-54. doi: 10.1002/jmr.633. J Mol Recognit. 2003. PMID: 14523936 Review.

2

A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis.

Froidevaux S, Calame-Christe M, Tanner H, Sumanovski L, Eberle AN. Froidevaux S, et al. J Nucl Med. 2002 Dec;43(12):1699-706. J Nucl Med. 2002. PMID: 12468522 Free article.

3

Homologous regulation of melanocortin-1 receptor (MC1R) expression in melanoma tumor cells in vivo.

Froidevaux S, Eberle AN. Froidevaux S, et al. J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):111-21. doi: 10.1081/rrs-120014590. J Recept Signal Transduct Res. 2002. PMID: 12503610

4

DOTA alpha-melanocyte-stimulating hormone analogues for imaging metastatic melanoma lesions.

Froidevaux S, Calame-Christe M, Sumanovski L, Tanner H, Eberle AN. Froidevaux S, et al. Ann N Y Acad Sci. 2003 Jun;994:378-83. doi: 10.1111/j.1749-6632.2003.tb03203.x. Ann N Y Acad Sci. 2003. PMID: 12851339

5

A gallium-labeled DOTA-alpha-melanocyte- stimulating hormone analog for PET imaging of melanoma metastases.

Froidevaux S, Calame-Christe M, Schuhmacher J, Tanner H, Saffrich R, Henze M, Eberle AN. Froidevaux S, et al. J Nucl Med. 2004 Jan;45(1):116-23. J Nucl Med. 2004. PMID: 14734683 Free article.

6

Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake.

Froidevaux S, Calame-Christe M, Tanner H, Eberle AN. Froidevaux S, et al. J Nucl Med. 2005 May;46(5):887-95. J Nucl Med. 2005. PMID: 15872364 Free article.

7

Dimeric DOTA-alpha-melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activity.

Bapst JP, Froidevaux S, Calame M, Tanner H, Eberle AN. Bapst JP, et al. Among authors: froidevaux s. J Recept Signal Transduct Res. 2007;27(5-6):383-409. doi: 10.1080/10799890701723528. J Recept Signal Transduct Res. 2007. PMID: 18097939

8

MSH radiopeptides for targeting melanoma metastases.

Eberle AN, Bapst JP, Calame M, Tanner H, Froidevaux S. Eberle AN, et al. Among authors: froidevaux s. Adv Exp Med Biol. 2010;681:133-42. doi: 10.1007/978-1-4419-6354-3_11. Adv Exp Med Biol. 2010. PMID: 21222266 Review.

9

Receptor targeting for tumor localisation and therapy with radiopeptides.

Heppeler A, Froidevaux S, Eberle AN, Maecke HR. Heppeler A, et al. Among authors: froidevaux s. Curr Med Chem. 2000 Sep;7(9):971-94. doi: 10.2174/0929867003374516. Curr Med Chem. 2000. PMID: 10911025 Review.

10

Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy.

Froidevaux S, Heppeler A, Eberle AN, Meier AM, Häusler M, Beglinger C, Béhé M, Powell P, Mäcke HR. Froidevaux S, et al. Endocrinology. 2000 Sep;141(9):3304-12. doi: 10.1210/endo.141.9.7683. Endocrinology. 2000. PMID: 10965902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters